SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to positive preclinical data for its intranasal naloxone hydrogel, with the community actively debating whether the stock will continue to squeeze or face dilution. The stock's low float and previous reverse splits are fueling volatility, while some traders are drawing comparisons to similar plays like $SMX and anticipating a potential multi-day run.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors anticipate earnings, focusing on the company's progress in AI automation and partnerships with major tech players like Nvidia and Google. The community is actively discussing the potential for a short squeeze and a significant breakout if earnings and guidance impress. Some analysts highlight UiPath's transition from RPA to a broader AI platform, while others remain cautious, pointing to the need for stronger revenue growth.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as analysts are turning bullish, with recent upgrades and raised price targets fueled by the anticipation of AI-driven growth and a new partnership with Palantir. The community is actively discussing the potential impact of this collaboration, while some investors express concerns about the stock's valuation and profitability metrics. Overall, SNOW is experiencing heightened attention due to positive sentiment and its strategic positioning within the cloud and AI sectors.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending as investors weigh the prospects of Anaphylm's upcoming FDA decision, especially against the backdrop of competitor SPRY's earnings. Community discussions revolve around the likelihood of approval, the potential impact of a competitor's petition, and the possibility of a buyout. Bullish investors highlight positive analyst ratings and the convenience of Anaphylm's delivery method, while others express concerns about market conditions and potential delays.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech Holding ($TIGR) is trending amid discussions of strong Q3 earnings, with community members highlighting record revenue and profit. Optimistic investors believe $TIGR is undervalued compared to competitors like $FUTU and $HOOD, focusing on its potential for growth in the Asian markets. Despite some concerns around resistance levels, many are anticipating a significant price increase.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce stock is trending due to its recent revenue forecast and discussions around AI integration, with the community debating the company's future and the potential impact of Agentforce. Despite mixed financial results and concerns about AI disrupting its core business, some analysts maintain a positive outlook. The stock's volatility and leadership are also focal points, with some suggesting a need for fresh perspectives.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to positive Phase 3 data for their DMD treatment, sparking buyout speculation and a potential short squeeze. The community is buzzing about the implications for FDA approval and the possibility of partnerships with larger pharmaceutical companies. However, some traders express skepticism, citing past FDA setbacks and statistical significance concerns.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports ($GENI) is trending amid analyst upgrades and raised price targets, driven by optimism surrounding its expanding data and technology platform. The community is discussing the company's strong positioning in the sports betting industry and potential for increased free cash flow conversion. Investors are also closely watching the upcoming Investor Day for further insights into the company's growth strategy.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses its potential, with some highlighting the QNX technology's growing adoption in the automotive industry and recent partnerships. Bullish sentiment is fueled by expectations for upcoming earnings and long-term growth, while others point to ongoing market manipulation. Investors are closely watching for a breakout above key resistance levels.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General's recent earnings beat and raised fiscal year guidance have sparked community discussion around the stock's potential. While some investors express frustration with its past performance compared to tech stocks, others point to its value proposition and resilience in a challenging economic environment, especially with strategic initiatives like store remodels and digital upgrades. Broader context includes commentary around consumer spending habits and how tariff impacts could level the playing field for discount retailers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain

Pacira BioSciences' iovera shows stronger, longer-lasting relief than RFA in a pilot CLBP study, highlighting its tissue-sparing approach and potential spine-care impact.

LSV Asset Management Has $2.28 Million Stake in Pacira BioSciences, Inc. $PCRX

LSV Asset Management grew its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 16.0% in the second quarter, according to its most recent Form 13F filing with the Securities and...

Pacira BioSciences, Inc. $PCRX Shares Sold by Bank of Montreal Can

Bank of Montreal Can reduced its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 65.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm...

Insider Selling: Pacira BioSciences (NASDAQ:PCRX) Insider Sells 3,960 Shares of Stock

Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) insider Jonathan Slonin sold 3,960 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The stock was sold at...

Integrated Quantitative Investments LLC Sells 28,621 Shares of Pacira BioSciences, Inc. $PCRX

Integrated Quantitative Investments LLC lessened its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 73.4% in the second quarter, according to its most recent filing...

Los Angeles Capital Management LLC Sells 41,645 Shares of Pacira BioSciences, Inc. $PCRX

Los Angeles Capital Management LLC lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 78.4% during the 2nd quarter, according to its most recent disclosure with the...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of "Hold" by Brokerages

Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have been given a consensus rating of "Hold" by the seven brokerages that are currently covering the company, MarketBeat.com...

Impax Asset Management Group plc Trims Stake in Pacira BioSciences, Inc. $PCRX

Impax Asset Management Group plc lowered its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 13.0% in the 2nd quarter, according to the company in its most recent disclosure with...

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Current Price	$24.19
Prev Close	$24.07
Open	$24.74
Dividend Yield	0.00%
50-Day Moving Average	$23.23
Beta	0.41
Avg. Volume	803,988.68
PE Ratio	54.23

52-Week High	$27.64
52-Week Low	$18.17
Market Capitalization	$1.04B
EPS (Annual)	-$2.15
Price to Book	1.43
Revenue Per Employee	$887,298.73
Enterprise Value/EBITDA	N/A

PCRX
Pacira BioSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PCRX News

PCRXPacira BioSciences Inc